Abstract
Recurrent glioblastoma multiforme is a lethal disease with currently available treatment options having a limited impact on outcome. In this article, current and novel therapeutic approaches in the treatment of recurrent glioblastoma multiforme, including chemotherapy, targeted molecular agents, virotherapy/gene therapy and immunotherapy and challenges in developing novel therapeutic agents for glioblastoma multiforme will be discussed.
Original language | English (US) |
---|---|
Pages (from-to) | 1593-1607 |
Number of pages | 15 |
Journal | Expert review of anticancer therapy |
Volume | 6 |
Issue number | 11 |
DOIs | |
State | Published - Nov 2006 |
Keywords
- Chemotherapy
- Gene therapy
- Glioblastoma multiforme
- Immunotherapy
- Recurrence
- Small molecule cell cycle inhibitors
ASJC Scopus subject areas
- Oncology
- Pharmacology (medical)